News
The investment round, valued at close to 100 million renminbi, or $13.8 million, was led by L'Oréal's China fund, its ...
The Beachwood-based company announced on Tuesday, May 20, that it has appointed Dr. David Llewellyn as its new CEO and as a ...
Dr. Aaron Carrithers brings a founder’s mindset and extensive firsthand experience, guiding biotech teams through complicated ...
Biotechnology has become the backbone of data-driven healthcare. With this advancement comes significant ethical and security ...
Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...
Operator: Good afternoon, and welcome to Oncolytics Biotech First Quarter Conference Call. All participants are in a listen-only mode.
PDS Biotechnology Corporation (NASDAQ: PDSB) Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation ...
Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...
VERSATILE-003 Phase 3 Site Initiations Underway Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting Conference call and webcast today at 8:00 ...
Performance data quoted represents past performance, which does not guarantee future results. Current performance may be lower or higher than the figures shown. Principal value and investment ...
At a time when the biotech sector has been struggling with a lack of investment, some companies have had to make decisions to change trial designs, whether that be reducing the number of patients or ...
design their planes, or biotech startup Treeline Biosciences find new drug candidates by simulating molecules. Its software was originally written with central processor units, or CPUs, in mind during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results